Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

The all-female Fun Friday Float event, now in its 11th year, raised money for prostate cancer research and consisted of a ...

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list ...

Other trials are exploring how well the immunotherapy prostate cancer drug sipuleucel-T (Provenge) works with radiation therapies like radium-223 (Xofigo). Provenge is also called a cancer vaccine.

Prostate Cancer Clinical Trials. Clinical research is an essential part of the scientific process that leads to new treatments and better care. Clinical trials can also be a way for patients to get ...

The research will use urine samples from prostate cancer patients collected in collaboration with physicians such as Dr. Thomas Gardner, a professor of urology and of microbiology and immunology ...

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...